Cita APA

Labidi-Galy, S., Rodrigues, M., Sandoval, J., Kurtz, J., Heitz, F., Mosconi, A., . . . Ray-Coquard, I. (2023). Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer.

Citación estilo Chicago

Labidi-Galy, S.I., et al. Association of Location of BRCA1 and BRCA2 Mutations With Benefit From Olaparib and Bevacizumab Maintenance in High-grade Ovarian Cancer. 2023.

Cita MLA

Labidi-Galy, S.I., et al. Association of Location of BRCA1 and BRCA2 Mutations With Benefit From Olaparib and Bevacizumab Maintenance in High-grade Ovarian Cancer. 2023.